Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children.

Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM.

Vaccine. 2013 Aug 20;31(37):3894-8. doi: 10.1016/j.vaccine.2013.06.051. Epub 2013 Jul 2.

PMID:
23831326
2.

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.

Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112.

PMID:
21810637
3.

Safety of the trivalent inactivated influenza vaccine among children: a population-based study.

France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R.

Arch Pediatr Adolesc Med. 2004 Nov;158(11):1031-6.

PMID:
15520339
4.

Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.

Greene SK, Rett MD, Vellozzi C, Li L, Kulldorff M, Marcy SM, Daley MF, Belongia EA, Baxter R, Fireman BH, Jackson ML, Omer SB, Nordin JD, Jin R, Weintraub ES, Vijayadeva V, Lee GM.

PLoS One. 2013 Jun 26;8(6):e67185. doi: 10.1371/journal.pone.0067185. Print 2013.

5.

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM; VSD Rapid Cycle Analysis Influenza Working Group.

Vaccine. 2012 Mar 2;30(11):2024-31. doi: 10.1016/j.vaccine.2012.01.027.

PMID:
22361304
6.

Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine.

Stockwell MS, Broder K, LaRussa P, Lewis P, Fernandez N, Sharma D, Barrett A, Sosa J, Vellozzi C.

JAMA Pediatr. 2014 Mar;168(3):211-9. doi: 10.1001/jamapediatrics.2013.4469.

PMID:
24395025
7.

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

JAMA. 2006 Oct 25;296(16):1990-7.

PMID:
17062862
8.

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A.

PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388. Epub 2011 Jan 11.

9.

Evaluating the safety of influenza vaccine using a claims-based health system.

McCarthy NL, Gee J, Lin ND, Thyagarajan V, Pan Y, Su S, Turnbull B, Chan KA, Weintraub E.

Vaccine. 2013 Dec 5;31(50):5975-82. doi: 10.1016/j.vaccine.2013.10.031. Epub 2013 Oct 19.

PMID:
24148577
10.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, Dobson S, Kellner JD, Kuhn S, Kollman T, MacKinnon-Cameron D, Smith B, Li Y, Halperin SA.

Vaccine. 2012 May 14;30(23):3389-94. doi: 10.1016/j.vaccine.2012.03.046. Epub 2012 Mar 30.

PMID:
22469860
11.

Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children.

Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ.

Vaccine. 2013 Feb 4;31(7):1123-8. doi: 10.1016/j.vaccine.2012.12.026. Epub 2012 Dec 20.

PMID:
23261040
12.

Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children.

Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E; Vaccine Safety Datalink Team.

Pediatrics. 2012 Jan;129(1):e54-9. doi: 10.1542/peds.2011-1294. Epub 2011 Dec 12.

PMID:
22157132
13.

Effectiveness of trivalent flu vaccine in healthy young children.

Blyth CC, Jacoby P, Effler PV, Kelly H, Smith DW, Robins C, Willis GA, Levy A, Keil AD, Richmond PC; WAIVE Study Team.

Pediatrics. 2014 May;133(5):e1218-25. doi: 10.1542/peds.2013-3707. Epub 2014 Apr 21.

14.

Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.

DeStefano F, Mullooly JP, Okoro CA, Chen RT, Marcy SM, Ward JI, Vadheim CM, Black SB, Shinefield HR, Davis RL, Bohlke K; Vaccine Safety Datalink Team.

Pediatrics. 2001 Dec;108(6):E112.

PMID:
11731639
15.
16.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
17.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

PMID:
22582210
18.

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL.

PLoS One. 2010 May 19;5(5):e10722. doi: 10.1371/journal.pone.0010722.

19.

The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age.

Goodman MJ, Nordin JD, Harper P, Defor T, Zhou X.

Pediatrics. 2006 May;117(5):e821-6. Erratum in: Pediatrics. 2006 Sep;118(3):1324.

PMID:
16651286
20.

Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.

HEI Collaborative Working Group on Air Pollution, Poverty, and Health in Ho Chi Minh City, Le TG, Ngo L, Mehta S, Do VD, Thach TQ, Vu XD, Nguyen DT, Cohen A.

Res Rep Health Eff Inst. 2012 Jun;(169):5-72; discussion 73-83.

PMID:
22849236

Supplemental Content

Support Center